-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Discussion on a Treatment Option for Sickle Cell Disease

Sponsor: Pfizer
Program: Product Theaters
Sunday, December 10, 2023: 11:30 AM-12:30 PM
Room 5A (San Diego Convention Center)
Kim Smith-Whitley, MD, Pfizer
No relevant conflicts of interest to declare.
For In-Person Participants Only
See more of: Product Theaters